Distribution
Introducing Global Market opportunities
Building on our patented, game-changing technology and its ability to accelerate the body’s own natural processes, DREAMADERM has secured significant wholesale, retail and healthcare distribution in multiple markets. As a “Made in USA” ingredient, products containing Dermatrix will support higher profit margins. The Mexico initial conservative points-of-sale commitments will drive immediate revenues while allowing significant and achievable regional scaling capabilities.
1-a
Wound Healing
Acute
Viral
Blister
Chronic
1-a
Aesthetic
Treatment
Recovery
OTC General Wound Healing
Phase 1a
Acute
Liquid Bandage Chronic
OTC Targeted Wound Healing
Phase 1b
Burn Blister Friction Blister Viral Blister
OTC Home Aesthetics
Phase 2
Micro-Needle Meso-Needle Viral Blister
Spa Aesthetics
Phase 3
Micro-Needle
Meso-Needle
Ablative Recovery
Advanced Aesthetics
Phase 4
Fillers
Botulinum Toxins
PDO Threads
PLLA
PRP
Advanced Medical / Aesthetics
Phase 5
Severe Burns
Diabetic Wounds
Initial
Mexico
Korea/Asia
USA
Phase in
South America
Middle east
Europe
Market Size
The global peptide therapeutics market size was estimated at $43.11 billion in 2022 and is expected to reach $76.83 billion by 2032
5.94% CAGR from 2023 to 2032
Wound Healing $23B projected market by 2027
Skin care world wide $150B projected market by 2027
.png)
.png)
Global Market
Diabetes Market Size
Diabetes Causes at least $966B in health expenditure
Overall, global diabetes-related health expenditure is estimated to rise to $1054B by 2045
.png)
Business Model
Initial Distribution
Mexico Manufacturing & Distribution
130M
Population
51M
Annual Tourism
Korea Manufacturing & Distribution
52M
Population
Global
Skincare Epicente
USA Manufacturing & Distribution
335M
Population
45M
Annual Tourism